Pentoxifylline
NDC 70954-668, Pentoxifylline, tablet, extended release, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-668
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074878
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-668 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PENTOXIFYLLINE400 mg/1
Pharmacologic classes
Blood Viscosity Reducer [EPC]; Hematologic Activity Alteration [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-668-10 | 70954066810 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-10) |
| 70954-668-20 | 70954066820 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-20) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9ca79c97-e4e5-4297-85eb-7a9b3d8083b5NADAC price for package 70954066810
GET /v1/drugs/nadac/70954066810NADAC price for package 70954066820
GET /v1/drugs/nadac/70954066820
Use it
Look up 70954-668 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-668 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-668. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.